A study on the relationship between RRM1 single nucleotide polymorphisms and clinical characteristics in lung cancer patients

A study on the relationship between RRM1 single nucleotide polymorphisms and clinical characteristics in lung cancer patients

Background and objective Gemcitabine is representative agent for chemotherapy in non-smallcell lung cancer (NSCLC). The aims of this study are to investigate the single nucleotide polymorphism (SNP) of the genesuch as ribonucleotide reductase subunit M1 (RRM1 ), which is the molecular target of gemc...

Full description

Bibliographic Details
Main Authors: Li LIN, Xiaoqing LIU, Santai SONG, Shengqi WANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2008-12-01
Series:Chinese Journal of Lung Cancer
Subjects:
Ribonucleotide reductase subunit M1
Single nucleotide polymorphism
Gemcitabine
Lung neoplasms
Online Access:http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2008.06.17&path%5B%5D=179

Internet

http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2008.06.17&path%5B%5D=179

Similar Items